-
公开(公告)号：US20190282541A1
公开(公告)日：2019-09-19
申请号：US16318198
申请日：2017-07-20
Applicant: EISAI R&D MANAGEMENT CO., LTD.
Inventor： Bruce A. LITTLEFIELD , Gary HENDLER
IPC: A61K31/357 , A61K31/4406 , A61K31/565 , A61P35/04
Abstract: The invention features methods for treating and preventing cancer (e.g., a hormone sensitive cancer) in a patient in need thereof by administering eribulin (e.g., eribulin mesylate) in combination with a histone deacetylase (HDAC) inhibitor.
Search Results
1
records
(took 0.013 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
